IL6 and hepatocellular carcinoma: In hepatocytes and liver cancer cells, the expression of HBx can activate the downstream signaling proteins IRAK-1, ERKs/p38 and NF-κB of MyD88, thereby promoting the synthesis and secretion of IL-6 and promoting the progress of HBV-related HCC (68).